Securing the Future of ADCs as Standard of Care Therapies by Unlocking Novel Payload Mechanisms to Combat Topo1 Resistance, Improving Translation of Efficacious & Tolerable ADCs to the Clinic & Enhancing Manufacturing Capabilities
With traditional ADCs now fulfilling their potential to reshape the standard of oncology care, the bioconjugate community is doubling down on differentiation to ensure the next wave of ADCs provide meaningful impact to patients in need.
Returning as the longest-standing and definitive ADC forum in Europe, the 16th World ADC London is the week for anyone working in or interested to learn about bioconjugates. Leverage cutting-edge R&D, development strategy, and unparalleled networking opportunities to harness ADC innovation and maximise the therapeutic index of your ADCs.
With 5 streams of end-to-end content spanning discovery, preclinical and translation, clinical lessons, process and analytical development, and manufacturing and supply chain: the 2026 agenda has been infused with trailblazing design, development, and production innovations to overcome patient resistance mechanisms and push ADCs to earlier line oncology treatments.
Uniting 800+ senior European ADC decision-makers across biopharma, clinicians, service providers, investors, and regulators, World ADC London is proud to bring the community together to kick off 2026 and shape the future of ADC development.
World ADC London is where the ADC field comes alive - showcasing new ideas, emerging technologies, and the people driving them forward. It’s the perfect place to spark concepts that can accelerate the next generation of breakthroughs for patients
This meeting provides the very best of cutting-edge technologies in ADC development and leaders in the field. A wonderful mix of industry and academia and a venue that supports making true and long-term connections that have lasted through the years and benefit our collective advances in the fight against the devastating challenges of cancer
World ADC London is a fantastic conference where experts in ADC come together to share expertise and camaraderie to achieve a common goal of helping patients
North American Presenting Companies
European Presenting Companies
Asian Presenting Companies
Cutting-Edge, End-to-End Scientific Content for All Stages of ADC Development
Explore the Full Event Guide
- 800+ Industry Attendees
- 110+ Global Speaker Faculty
- 5 Tracks of End-to-End ADC Content
- Comprehensive One-on-One PartneringTM & Informal Networking Opportunities
- Europe’s Largest & Definitive ADC Forum
Official Partners
Lead Partner
Senior Partners
Attending Companies Include
Explore the Agenda
Hear the latest industry insights and discover cutting-edge, end-to-end ADC content from early discovery to late-stage manufacturing.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.